Item 5. Market for Registrant’s Common Equity
ITEM 5 MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Prices
Our common stock is traded on the Nasdaq Global Select Market under the symbol “BRKR”.
As of December 31, 2025, there were approximately 59 holders of record of our common stock. This number does not include individual beneficial owners of shares held in nominee name or within clearinghouse positions of brokerage firms and banks.
Dividends
We have paid dividends on common stock since 2016 and increased the dividend amount once in 2022 to $0.05 per share of our issued and outstanding common stock. In February 2026, we announced that our Board had approved a quarterly dividend for the first quarter of 2026 of $0.05 per share, payable in April. Future dividend payments, if any, are subject to approval of our Board of Directors.
Stock Price Performance Graph
The graph below compares Bruker Corporation’s annual percentage change in cumulative total return on common shares over the past five years ended December 31, 2025, with the cumulative total return of companies comprising the Nasdaq US Benchmark TR Index and the SIC Code 3826 Laboratory Analytical Instruments Index. This presentation assumes that $100 was invested in shares of the relevant issuers on December 31, 2020, and that dividends received were immediately invested in additional shares. The graph shows the value of the initial $100 investment at one-year intervals for the fiscal years presented.
Cumulative Total Return Index for:
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Bruker Corporation
$
100.00
$
155.36
$
126.95
$
136.88
$
109.52
$
88.45
Nasdaq US Benchmark TR Index
100.00
125.89
101.05
127.76
159.03
186.96
SIC Code 3826 Laboratory Analytical Instruments
$
100.00
$
126.33
$
84.24
$
74.68
$
70.22
$
67.66
The data for this performance graph was compiled by Zack’s Investment Research, Inc. and is used with its permission.
41
Table of Contents
Issuer Purchases of Securities
In May 2023, the Company’s Board of Directors approved a share repurchase program (the “2023 Repurchase Program”) authorizing the purchase of up to $500.0 million of the Company’s common stock over a two-year period, in amounts, at prices, and at such times as management deems appropriate, subject to market conditions, legal requirements, and other considerations. During the year ended December 31, 2025, the Company purchased a total of 200,731 shares at an aggregate cost of $10.0 million under the 2023 Repurchase Program. The 2023 Repurchase Program expired in May 2025 and has not been renewed.
ITEM 6 RESERVED